Multi-center, Prospective, Non-interventional, Observational Cohort Study to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients with Non-valvular Atrial Fibrillation in Japanese Clinical Practice

Trial Profile

Multi-center, Prospective, Non-interventional, Observational Cohort Study to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients with Non-valvular Atrial Fibrillation in Japanese Clinical Practice

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Atrial fibrillation; Embolism; Stroke
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms EXPAND
  • Most Recent Events

    • 01 Jun 2014 Status changed from recruiting to active, no longer recruiting according to trial design and baseline characteristics published in the Tohoku Journal of Experimental Medicine.
    • 11 Jul 2013 Planned End Date (31 Mar 2016) added as reported by University Hospital Medical Information Network - Japan.
    • 22 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top